Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Sleep-Aligned Fasting Linked to Cardiometabolic Benefits

An overnight fasting regimen beginning at least 3 hours prior to sleep shows potential benefits in blood pressure, heart rate dipping, and glucose regulation.

How to Get Your Daily Fiber Without Overeating

Most Americans fall short of fiber targets. Here’s how to help people understand how much they need — and how to get higher daily amounts without eating too much.

Med Op-Ed: Time Travel Edition

A 150-year-old formula for cold relief, a call for humility in the practice of preventive medicine, and one doctor’s concerns about the use of ‘informed consent.’

Indoor Air Pollution Linked to Inflammation in Heart Failure

Indoor air pollutants are associated with changes in inflammatory markers and cardiac autonomic dysregulation in people with heart failure.

5 Factors May Predict Stroke Risk Years After First Event

A new study finds hypertension, smoking history, and three ischemic stroke subtypes are linked to increased secondary stroke risk years after patients had their first minor stroke event.

Care Continuity With GPs May Improve Hypertension Detection

Continuity of care in general practice shows a dose-dependent link to higher rates and earlier detection of hypertension in adults without existing heart conditions.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Latest News

An overnight fasting regimen beginning at least 3 hours prior to sleep shows potential benefits in blood pressure, heart rate dipping, and glucose regulation.

Most Americans fall short of fiber targets. Here’s how to help people understand how much they need — and how to get higher daily amounts without eating too much.

A 150-year-old formula for cold relief, a call for humility in the practice of preventive medicine, and one doctor’s concerns about the use of ‘informed consent.’

Indoor air pollutants are associated with changes in inflammatory markers and cardiac autonomic dysregulation in people with heart failure.

A new study finds hypertension, smoking history, and three ischemic stroke subtypes are linked to increased secondary stroke risk years after patients had their first minor stroke event.

Continuity of care in general practice shows a dose-dependent link to higher rates and earlier detection of hypertension in adults without existing heart conditions.

News All Time

EU Widens Access for Rare Lipid and Obesity Disorders

The European Medicines Agency has backed wider use of treatments for rare cholesterol and obesity disorders, offering new hope for adult and pediatric patients with limited options.

Health Risk May Vary by Alcohol Type

Beer, cider, and spirits are more harmful than wine at low-to-moderate consumption levels.

PCI Reduces Symptoms of Chronic Total Occlusion

A small carefully constructed and blinded clinical trial confirms that percutaneous intervention significantly relieves angina in patients with chronic total obstruction.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Extensive Screen Time Tied to CV Risk

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

Knowledge Areas: Transforming Hospital Care

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

When Self-Reflection Becomes a Physician’s Enemy

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

The Clinical Dilemma of Withholding Futile Treatment

When the ‘default’ is aggressive care, how do clinicians handle nonbeneficial treatment?

Air Pollution Tied to Myocardial Fibrosis in Normal Hearts

Chronic exposure to fine particulate matter is associated with changes in cardiac magnetic resonance markers of early myocardial fibrosis in patients with structurally normal hearts.

Long-Term Data Support Early SAVR in Severe Aortic Stenosis

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic stenosis, according to long-term data from the RECOVERY trial.

Novel Wearable Detects Aortic Stenosis

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity of aortic stenosis.

EMA Backs Orodispersible Furosemide for Edema in Children

The European regulator recommends granting pediatric use marketing authorization for Bopediat to treat children with oedema and hypertension from chronic kidney disease.

GI Bleeding Deaths Rise in Wake of Increased DOAC Use

Deaths from gastrointestinal bleeding have increased, but fatal bleeding risk per anticoagulated patient has declined despite the widespread use of direct oral anticoagulants.

Recommended News For You

Aster Whitefield Hospital, with 506 beds, opened.

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

Never in a million years did I think I'd have to limit my chemotherapy.

Short-course radiation matches standard therapy for endometrial cancer

Women are more susceptible to the stress caused by inflation.

Recommended Articles For You

An Overview Of Daunorubicin: What Is It Used For And How Does It Work? 

Exploring the Hope of New Treatments for Rhabdomyosarcoma 

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies 

Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New study elucidates obesity's role in fueling breast cancer progression

2.

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

3.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

4.

The Truth About Apple AirPods

5.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

1.

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025

2.

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances

3.

Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation

4.

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology

5.

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot